• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰结直肠癌筛查计划第一年中实时监测结果以及通过调整粪便免疫化学检测截断值进行优化

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

机构信息

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

出版信息

Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24.

DOI:10.1053/j.gastro.2016.11.022
PMID:27890769
Abstract

BACKGROUND & AIMS: After careful pilot studies and planning, the national screening program for colorectal cancer (CRC), with biennial fecal immunochemical tests (FITs), was initiated in The Netherlands in 2014. A national information system for real-time monitoring was developed to allow for timely evaluation. Data were collected from the first year of this screening program to determine the importance of planning and monitoring for optimal screening program performance.

METHODS

The national information system of the CRC screening program kept track of the number of invitations sent in 2014, FIT kits returned, and colonoscopies performed. Age-adjusted rates of participation, the number of positive test results, and positive predictive values (PPVs) for advanced neoplasia were determined weekly, quarterly, and yearly.

RESULTS

In 2014, there were 741,914 persons invited for FIT; of these, 529,056 (71.3%; 95% CI, 71.2%-71.4%) participated. A few months into the program, real-time monitoring showed that rates of participation and positive test results (10.6%; 95% CI, 10.5%-10.8%) were higher than predicted and the PPV was lower (42.1%; 95% CI, 41.3%-42.9%) than predicted based on pilot studies. To reduce the burden of unnecessary colonoscopies and alleviate colonoscopy capacity, the cut-off level for a positive FIT result was increased from 15 to 47 μg Hb/g feces halfway through 2014. This adjustment decreased the percentage of positive test results to 6.7% (95% CI, 6.6%-6.8%) and increased the PPV to 49.1% (95% CI, 48.3%-49.9%). In total, the first year of the Dutch screening program resulted in the detection of 2483 cancers and 12,030 advanced adenomas.

CONCLUSIONS

Close monitoring of the implementation of the Dutch national CRC screening program allowed for instant adjustment of the FIT cut-off levels to optimize program performance.

摘要

背景与目的

在经过仔细的试点研究和规划后,荷兰于 2014 年启动了全国结直肠癌(CRC)筛查计划,每两年进行一次粪便免疫化学检测(FIT)。建立了一个全国实时监测信息系统,以进行及时评估。本研究收集了该筛查计划实施第一年的数据,以确定规划和监测对优化筛查计划效果的重要性。

方法

CRC 筛查计划的全国信息系统记录了 2014 年发送的邀请数量、返回的 FIT 试剂盒数量和进行的结肠镜检查数量。每周、每季度和每年计算参与率、阳性检测结果数量和高级别瘤变的阳性预测值(PPV)的年龄调整率。

结果

2014 年,共有 741914 人接受 FIT 邀请;其中,529056 人(71.3%;95%CI,71.2%-71.4%)参与。该计划实施数月后,实时监测显示,参与率和阳性检测结果(10.6%;95%CI,10.5%-10.8%)高于预测值,PPV(42.1%;95%CI,41.3%-42.9%)也低于基于试点研究的预测值。为了减少不必要的结肠镜检查负担并缓解结肠镜检查能力的压力,2014 年中期将阳性 FIT 结果的截止值从 15μgHb/g 粪便提高到 47μgHb/g 粪便。这一调整使阳性检测结果的百分比降低至 6.7%(95%CI,6.6%-6.8%),PPV 提高至 49.1%(95%CI,48.3%-49.9%)。总体而言,荷兰筛查计划的第一年共发现 2483 例癌症和 12030 例高级别腺瘤。

结论

对荷兰全国 CRC 筛查计划实施情况的密切监测,使 FIT 截止值的即时调整成为可能,从而优化了计划效果。

相似文献

1
Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.荷兰结直肠癌筛查计划第一年中实时监测结果以及通过调整粪便免疫化学检测截断值进行优化
Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24.
2
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
3
Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.粪便免疫化学试验在结直肠癌筛查中的应用:不同截断值的结肠镜检查结果。
J Gastroenterol Hepatol. 2019 Jan;34(1):103-112. doi: 10.1111/jgh.14373. Epub 2018 Jul 29.
4
Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.更高的粪便免疫化学检测截断值对后续轮次结直肠筛查项目中检出的病理结果的影响。
Gastrointest Endosc. 2019 Mar;89(3):518-522. doi: 10.1016/j.gie.2018.08.015. Epub 2018 Aug 22.
5
Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.基于粪便免疫化学试验的结直肠癌筛查方案的长期效果。
Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3.
6
Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.较低的粪便免疫化学检测截断值可提高系统层面筛查结直肠癌的检出率。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):647-653. doi: 10.1016/j.cgh.2019.04.077. Epub 2019 May 11.
7
Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.基于人群的结直肠癌筛查计划中定量粪便免疫化学检测结果与结肠镜下肿瘤性发现的相关性:一项前瞻性研究。
Can J Gastroenterol Hepatol. 2016;2016:4650471. doi: 10.1155/2016/4650471. Epub 2016 Dec 26.
8
Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.增加结直肠癌筛查计划的筛查年龄和粪便血红蛋白截断浓度的效果。
Clin Gastroenterol Hepatol. 2016 Dec;14(12):1771-1777. doi: 10.1016/j.cgh.2016.08.016. Epub 2016 Aug 24.
9
Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.粪便免疫化学检测血红蛋白浓度与结直肠高级别腺瘤长期进展的相关性。
Gastroenterology. 2017 Nov;153(5):1251-1259.e2. doi: 10.1053/j.gastro.2017.07.034. Epub 2017 Jul 29.
10
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.荷兰结直肠癌筛查项目第二轮:粪便免疫化学检测截断值提高对筛查效果的影响。
Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9.

引用本文的文献

1
Factors associated with false fecal immunochemical test results in colorectal cancer screening.结直肠癌筛查中与粪便免疫化学检测结果假阳性相关的因素。
World J Gastrointest Oncol. 2025 Apr 15;17(4):101487. doi: 10.4251/wjgo.v17.i4.101487.
2
Linear endo-ultrasonographic signs of muscularis propria invasion in early rectal cancer.早期直肠癌肌层浸润的线性腔内超声征象
Tech Coloproctol. 2024 Dec 20;29(1):29. doi: 10.1007/s10151-024-03073-4.
3
Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT-based colorectal cancer screening.
达到筛查年龄上限后的间期癌风险:基于粪便免疫化学检测的结直肠癌筛查中的风险分层告知
Int J Cancer. 2025 May 1;156(9):1783-1790. doi: 10.1002/ijc.35294. Epub 2024 Dec 19.
4
Deep learning for segmentation of colorectal carcinomas on endoscopic ultrasound.用于内镜超声下结直肠癌分割的深度学习
Tech Coloproctol. 2024 Dec 13;29(1):20. doi: 10.1007/s10151-024-03056-5.
5
Does Colonoscopy as a First Screening Test Still Make Sense?-Counterpoint.结肠镜检查作为初次筛查测试是否仍有意义?——反对观点
Dig Dis Sci. 2024 Dec 6. doi: 10.1007/s10620-024-08695-0.
6
Performance of Faecal Immunochemical Testing for Colorectal Cancer Screening at Varying Positivity Thresholds.不同阳性阈值下粪便免疫化学检测用于结直肠癌筛查的性能
Aliment Pharmacol Ther. 2025 Jan;61(1):122-131. doi: 10.1111/apt.18314. Epub 2024 Oct 7.
7
Pattern of Participation in Colorectal Cancer Screening from a Population-Based Screening Program in Iran.伊朗基于人群的结直肠癌筛查项目中参与筛查的模式。
Arch Iran Med. 2024 Aug 1;27(8):407-413. doi: 10.34172/aim.31072.
8
Adherence to follow-up and resource use after abnormal FIT-screening: Evaluation of the Danish colorectal cancer screening program.粪便免疫化学检测筛查异常后的随访依从性及资源利用情况:丹麦结直肠癌筛查项目评估
Endosc Int Open. 2024 May 3;12(5):E649-E658. doi: 10.1055/a-2297-9622. eCollection 2024 May.
9
Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program.基于国家粪便免疫化学检测的结直肠癌筛查项目中的结肠镜检查后结直肠癌
Endoscopy. 2024 May;56(5):364-372. doi: 10.1055/a-2230-5563. Epub 2023 Dec 15.
10
Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot.新西兰肠道筛查试验中阴性粪便免疫化学试验后的间隔期结肠癌。
BMJ Open Gastroenterol. 2023 Nov 24;10(1):e001233. doi: 10.1136/bmjgast-2023-001233.